Enhancing safety with potassium phosphates injection.

Area of Science:

• Clinical Pharmacy
• Patient Safety
• Medication Error Prevention

Background:

• Inadvertent administration of concentrated potassium chloride has led to patient deaths globally.
• Potassium phosphate vials contain over double the potassium concentration of potassium chloride concentrates.
• Existing documentation highlights the dangers of concentrated potassium chloride errors.

Purpose of the Study:

• To enhance safety protocols for intravenous potassium phosphate administration.
• To raise awareness regarding the high potassium concentration in potassium phosphate injections.
• To prevent serious patient harm and fatalities associated with medication errors.

Main Methods:

• Information reprinted with permission from an ISMP Canada Safety Bulletin (April 25, 2006).
• Review of documented cases and comparative analysis of potassium concentrations.
• Dissemination of safety information to healthcare professionals.

Main Results:

• Intravenous potassium phosphate, if inadequately diluted or administered too rapidly, can cause severe patient harm.
• The high potassium concentration in potassium phosphate presents a significant risk if not managed properly.
• Potential for fatal outcomes exists, similar to documented potassium chloride errors.

Conclusions:

• Healthcare providers must exercise extreme caution with potassium phosphate injections.
• Strict adherence to dilution guidelines and administration rates is essential.
• Enhanced vigilance is required to prevent medication errors with high-potassium solutions.